Aspreva Pharmaceuticals CORP

CIK 1314026 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aspreva Pharmaceuticals CORP.

Recent SEC filings

FiledFormAccession number
Jan 31, 2012CT ORDER9999999997-12-000577
Jan 31, 2012CT ORDER9999999997-12-000578
Feb 12, 2009SC 13G/A0001104659-09-008812
Feb 14, 2008SC 13G/A0000903423-08-000126
Jan 11, 200815-12G0001341004-08-000070
Jan 8, 20088-K0001341004-08-000048
Jan 8, 2008SC 13D/A0001341004-08-000047
Jan 3, 200825-NSE0001354457-08-000002
Dec 24, 20078-K0001279569-07-001841
Dec 20, 20078-K0001279569-07-001834
Dec 19, 20078-K0001279569-07-001813
Dec 17, 20078-K0001279569-07-001803
Nov 23, 20078-K0000945234-07-000681
Nov 6, 200710-Q0000945234-07-000653
Nov 5, 20078-K/A0001279569-07-001590
Nov 1, 20078-K0001279569-07-001562
Oct 29, 2007SC 13D0001341004-07-002859
Oct 23, 20078-K0000950134-07-021755
Oct 18, 20078-K0000950134-07-021546
Oct 17, 20078-K0001279569-07-001496
Sep 26, 20078-K0001279569-07-001406
Sep 11, 20078-K0001279569-07-001339
Aug 30, 20078-K0001279569-07-001299
Aug 8, 200710-Q0001130319-07-000549
Jul 31, 20078-K0001279569-07-001114